Literature DB >> 28664744

Therapeutic effects of melatonin and quercetin in improvement of hepatic steatosis in rats through supression of oxidative damage.

M Esrefoglu, A Cetin, E Taslidere, H Elbe, B Ates, O E Tok, M S Aydin.   

Abstract

BACKGROUND: Non-alcoholic steatohepatitis, a cause of cirrhosis, is characterized by fatty infiltration of the liver, inflammation, hepatocellular damage and fibrosis. The aim of the present study was to investigate the effects of melatonin and quercetin on CCl4-induced steatosis characterized by fatty infiltration of the liver, inflammation, hepatocellular damage and fibrosis.
METHODS: Rats were divided into 5 groups: Ethanol, Olive oil, CCl4, CCl4+Melatonin (CCl4+Mel), CCl4+Quercetin. Rats were sacrificed and livers were removed for being evaluated by histopathological, immunohistochemical and biochemical methods.
RESULTS: In CCI4 group, vacuolization, vascular congestion, haemorrhage, necrosis, and inflammatory infiltration were identified. The mean tissue MDA level was increased, whereas GSH level and SOD and CAT activities were decreased in comparison with ethanol and olive oil groups. MDA levels were decreased in CCI4+Quercetin and CCI4+Mel groups versus CCI4 group. CAT activity of CCI4+Mel group was higher than that of CCI4 and CCI4+Quercetin groups. The mean tissue GSH level of CCI4+Mel group versus CCI4 group was significantly increased.
CONCLUSIONS: By the means of histopathological examination, we suggest that both agents are beneficial against necrotic and apoptotic cell death during steatosis. Thus, melatonin and quercetin might be beneficial in the improvement of hepatic steatosis by supporting conventional therapy in humans (Tab. 1, Fig. 5, Ref. 53).

Entities:  

Keywords:  antioxidant; melatonin; quercetin liver.

Mesh:

Substances:

Year:  2017        PMID: 28664744     DOI: 10.4149/BLL_2017_066

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  6 in total

1.  Melatonin Modulation of Sirtuin-1 Attenuates Liver Injury in a Hypercholesterolemic Mouse Model.

Authors:  Francesca Bonomini; Gaia Favero; Luigi Fabrizio Rodella; Mohammed H Moghadasian; Rita Rezzani
Journal:  Biomed Res Int       Date:  2018-02-04       Impact factor: 3.411

2.  Quercetin and its role in biological functions: an updated review.

Authors:  Jae Kwang Kim; Sang Un Park
Journal:  EXCLI J       Date:  2018-08-27       Impact factor: 4.068

3.  Revealing the Mechanism of Huazhi Rougan Granule in the Treatment of Nonalcoholic Fatty Liver Through Intestinal Flora Based on 16S rRNA, Metagenomic Sequencing and Network Pharmacology.

Authors:  Yingying Liu; Yingying Tan; Jiaqi Huang; Chao Wu; Xiaotian Fan; Antony Stalin; Shan Lu; Haojia Wang; Jingyuan Zhang; Fanqin Zhang; Zhishan Wu; Bing Li; Zhihong Huang; Meilin Chen; Guoliang Cheng; Yanfang Mou; Jiarui Wu
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

4.  Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology.

Authors:  Rui Qiang; Ya Zhang; Yanhong Wang
Journal:  Dis Markers       Date:  2022-10-04       Impact factor: 3.464

5.  Beneficial effects of melatonin on liver fibrosis: A systematic review of current biological evidence.

Authors:  Beatriz San-Miguel; Paula Fernández-Palanca; José L Mauriz; María J Tuñón; Javier González-Gallego
Journal:  J Cell Physiol       Date:  2022-04-11       Impact factor: 6.513

6.  Effects of Sleep Quality on Melatonin Levels and Inflammatory Response after Major Abdominal Surgery in an Intensive Care Unit.

Authors:  Necdet Fatih Yaşar; Bartu Badak; Ağgül Canik; Sema Şanal Baş; Sema Uslu; Setenay Öner; Ersin Ateş
Journal:  Molecules       Date:  2017-09-12       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.